David H. Mack - Mar 8, 2022 Form 4 Insider Report for PMV Pharmaceuticals, Inc. (PMVP)

Role
President and CEO, Director
Signature
/s/ David H. Mack
Stock symbol
PMVP
Transactions as of
Mar 8, 2022
Transactions value $
$27,400
Form type
4
Date filed
3/9/2022, 03:33 PM
Previous filing
Feb 28, 2022
Next filing
Apr 29, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PMVP Common Stock Options Exercise $27.4K +20K +74.16% $1.37* 47K Mar 8, 2022 Direct
transaction PMVP Common Stock Gift $0 -40K -21.29% $0.00 148K Mar 9, 2021 See footnote F1
transaction PMVP Common Stock Gift $0 +40K +100% $0.00 80K Mar 9, 2021 See footnote F2
holding PMVP Common Stock 57K Mar 8, 2022 See footnote F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PMVP Stock Option (right to buy) Options Exercise $0 -20K -8.31% $0.00 221K Mar 8, 2022 Common Stock 20K $1.37 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares are held of record by The Mack-Mulligan Revocable Trust. The reporting person disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein.
F2 The shares are held of record by the Stinson 2021 Irrevocable Trust. The reporting person disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein.
F3 The shares are held of record by the Mack/Mulligan 2020 Irrevocable Descendants' Trust. The reporting person disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein.
F4 The shares subject to the option are fully vested and immediately exercisable.